Surgihoney™ is a bioengineered, medical grade honey wound gel. The product is approved for use on a broad range of wounds – acute, chronic, infected. Surgihoney™ supplements the healing properties of honey with potent antimicrobial activity.
Surgihoney™ supports the body to fight infection and heal via the sustained release of safe, low levels of Reactive Oxygen™[1,2]. It has broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains such as MRSA, Pseudomonas aeruginosa and E. coli.. Laboratory testing has demonstrated superior efficacy in preventing biofilm formation compared to standard medical honeys in vitro.
Surgihoney™ combines the healing properties of honey with effective antimicrobial activity. Due to its sustained release of safe, low levels of Reactive Oxygen™ (RO®) it is particularly suitable for the treatment of infected wounds.
- Wound barrier & moist healing environment
- Effective de-sloughing agent
- Local wound nutrition
- Broad spectrum activity against bacteria and fungi
- Reduce bacterial load
- Anti-biofilm action in vitro
- Reduce inflammation & pain
- Safe to use (non-toxic)
- Improve healing
Indications for Surgihoney™
- Leg ulcers
- Diabetic ulcers
- Pressure ulcers
- Surgical wounds
- Infected wounds
- Burns & skin grafts
- Cuts & abrasions
Surgihoney™ is manufactured by Matoke Holdings Limited www.surgihoneyro.com.
For further information please contact the office on 01482 631606 or email email@example.com.
 Cooke, J., Dryden, M., Patton, T., Brennan, J. and Barrett, J. (2015) The antimicrobial activity of prototype modified honeys that generate Reactive Oxygen™ species (ROS) hydrogen peroxide, 8(1).
 Dunnill, C., Patton, T., Brennan, J., et al. (2015) Reactive Oxygen™ species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process.
 Dryden, M., Lockyer, G., Kordo, S. and Cooke, J. (2014) Engineered honey: in vitro antimicrobial activity of a novel topical wound care treatment. Journal of Global Antimicrobial Resistance, 2(3).
 Halstead, F.D., Webber, M.A., et al. (2016) In vitro activity of an engineered honey, medical-grade honeys and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates. JWC, 25(2).
 Dryden, M., et al. (2016) A multi-centre clinical evaluation of Reactive Oxygen™ topical wound gel in 114 wounds.